These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9112299)

  • 1. Features and outcome of Pneumocystis carinii pneumonia according to risk category for HIV infection.
    Laing R; Brettle R; Leen C; Hulks G
    Scand J Infect Dis; 1997; 29(1):57-61. PubMed ID: 9112299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States.
    Dworkin MS; Hanson DL; Navin TR
    J Infect Dis; 2001 May; 183(9):1409-12. PubMed ID: 11294675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromized patients with and without HIV infection.
    Enomoto T; Azuma A; Kohno A; Kaneko K; Saito H; Kametaka M; Usuki J; Gemma A; Kudoh S; Nakamura S
    Respirology; 2010 Jan; 15(1):126-31. PubMed ID: 19947989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group.
    Lundgren JD; Barton SE; Lazzarin A; Danner S; Goebel FD; Pehrson P; Mulcahy F; Kosmidis J; Pedersen C; Phillips AN
    Clin Infect Dis; 1995 Jul; 21(1):106-13. PubMed ID: 7578718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumocystis pneumonia in South African children diagnosed by molecular methods.
    Morrow BM; Samuel CM; Zampoli M; Whitelaw A; Zar HJ
    BMC Res Notes; 2014 Jan; 7():26. PubMed ID: 24410938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
    ; Mocroft A; Reiss P; Kirk O; Mussini C; Girardi E; Morlat P; Stephan C; De Wit S; Doerholt K; Ghosn J; Bucher HC; Lundgren JD; Chene G; Miro JM; Furrer H
    Clin Infect Dis; 2010 Sep; 51(5):611-9. PubMed ID: 20645862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy.
    Ball SC
    AIDS Read; 2007 Dec; 17(12):583-6, 593. PubMed ID: 18178976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia.
    Ruffini DD; Madhi SA
    AIDS; 2002 Jan; 16(1):105-12. PubMed ID: 11741168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of chemoprophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection. HIV Outpatient Study (HOPS) Investigators.
    Yangco BG; Von Bargen JC; Moorman AC; Holmberg SD
    Ann Intern Med; 2000 Feb; 132(3):201-5. PubMed ID: 10651600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pneumocystis carinii pneumonia as the first presentation of HIV infection in patients older than fifty.
    Jedlovsky V; Fleischman JK
    AIDS Patient Care STDS; 2000 May; 14(5):247-9. PubMed ID: 10833811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.
    Stansell JD; Osmond DH; Charlebois E; LaVange L; Wallace JM; Alexander BV; Glassroth J; Kvale PA; Rosen MJ; Reichman LB; Turner JR; Hopewell PC
    Am J Respir Crit Care Med; 1997 Jan; 155(1):60-6. PubMed ID: 9001290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
    Weverling GJ; Mocroft A; Ledergerber B; Kirk O; Gonzáles-Lahoz J; d'Arminio Monforte A; Proenca R; Phillips AN; Lundgren JD; Reiss P
    Lancet; 1999 Apr; 353(9161):1293-8. PubMed ID: 10218526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami: 1987-1990.
    Bennett CL; Horner RD; Weinstein RA; Kessler HA; Dickinson GM; Pitrak DL; Gilman SC; George WL; Cohn SE; Simberkoff MS
    J Infect Dis; 1995 Jul; 172(1):312-5. PubMed ID: 7797940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation of pulmonary mycetoma in HIV-infected patients.
    Greenberg AK; Knapp J; Rom WN; Addrizzo-Harris DJ
    Chest; 2002 Sep; 122(3):886-92. PubMed ID: 12226028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
    Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
    Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids improve survival of children with AIDS and Pneumocystis carinii pneumonia.
    Sleasman JW; Hemenway C; Klein AS; Barrett DJ
    Am J Dis Child; 1993 Jan; 147(1):30-4. PubMed ID: 8093422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin salvage therapy in Pneumocystis jirovecii pneumonia.
    Lee WS; Hsueh PR; Hsieh TC; Chen FL; Ou TY; Jean SS
    J Microbiol Immunol Infect; 2017 Aug; 50(4):547-548. PubMed ID: 27094385
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
    Alvarez-Martínez MJ; Miró JM; Valls ME; Mas J; de la Bellacasa JP; Sued O; Solé M; Rivas PV; de Lazzari E; Benito N; García F; Agustí C; Wilson PE; Gatell JM; Jiménez de Anta MT; Meshnick SR; Moreno A
    Diagn Microbiol Infect Dis; 2010 Sep; 68(1):60-5. PubMed ID: 20727472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.